TrialClinical trialPHN-02602026-04-29 19:00 CT
A Study to Test Whether Survodutide (BI 456906) Helps Chinese People Living With Overweight or Obesity to Lose Weight
Source · ClinicalTrials.gov: survodutide
TLDR
ClinicalTrials.gov lists a study of survodutide (BI 456906) in Chinese adults with overweight or obesity as completed. The trial randomly assigned participants to three groups to compare survodutide with placebo; the provided excerpt contains no results.
01—Key points
- 01The study compared two survodutide groups with one placebo group.
- 02Participants were in the study for about 21 months.
- 03Doctors monitored body weight, participants’ health, and unwanted effects.
Why it matters Editorial
The study was designed to assess survodutide’s weight-loss effects and safety in this population, but the excerpt does not establish its outcomes.
Summary generated with AI and reviewed by an editor. The original source governs; summaries can contain errors. Information only — not medical advice. Full disclaimer.
No related news yet.